Skip to content

Virtual Reality Based Interventions After Brain Injury

The Effectiveness of Virtual Reality Based Interventions on Cognitive Function After Brain Injury

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07586566
Enrollment
15
Registered
2026-05-14
Start date
2026-06-01
Completion date
2028-07-31
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Brain Injury (Including Stroke)

Keywords

cognition, rehabilitation, vr, virtual reality, ar, augmented reality, acquired brain injury

Brief summary

After a brain injury, cognitive impairments are common, affecting an individual's independence and quality of life. Although various training programs are used in rehabilitation, it remains unclear how effective they are in real-life settings. The project now being planned at CogTech, a technology-driven rehabilitation unit at Danderyd Hospital, aims to evaluate new methods that can enhance both training effectiveness and motivation. In the project, the effect of game-based training in virtual reality (VR) on cognition will be evaluated. VR offers a more realistic and engaging environment, which may improve the transfer of training outcomes to everyday situations. In this feasibility study, ten patients at the clinic will receive VR-training at 15 occasions in addition to rehabilitation as usual. The results may contribute to the development of more individualized rehabilitation, reduced treatment times, and improved quality of life for people with brain injury.

Detailed description

The overarching aim of this project is to evaluate the effectiveness of CogTech's technology-assisted interventions on cognitive and visual functioning in patients undergoing rehabilitation following acquired brain injury. Within the scope of this umbrella project, the initial intervention to be evaluated is VR gaming. The first aim is to investigate the feasibility of a VR-game clinical trial. The feasibility study will be conducted with approximately ten patients. The primary aim of this phase is to inform key design decisions for a subsequent RCT (including 90 patients). Specifically, the feasibility study will evaluate: the suitability of different VR games and headsets, the optimal intensity and duration of the VR-based training sessions, and the appropriate level and format of therapist involvement during the intervention. Participants will be recruited from both the inpatient and outpatient units at the Department of Rehabilitation Medicine, Danderyd Hospital. Before enrollment in a rehabilitation program, all patients are comprehensively assessed by the rehabilitation team ("the assessment phase", with a typical duration of two to three weeks). During this phase, a neuropsychological assessment is performed by a neuropsychologist and an activity-based assessment is performed by an occupational therapist. Based on these assessments, the rehabilitation team concludes whether attention deficits are present and direct attention training is indicated (Attention Process Training11 is the standard at the clinic). Participants will be recruited among these patients. The VR intervention will be offered as an add-on to the other interventions in the rehabilitation program. The content of the rehabilitation program varies between patients, but typically includes attention process training for attention deficits, strategy training for executive deficits and physiotherapy for physical and motor deficits. The length of the rehabilitation program is typically 12 to 16 weeks. In the feasibility study, eligible patients will consequently be informed about the study after the clinical assessment phase and will be asked for informed consent (n=10). Following the recruitment to the VR-intervention, five patients will be asked to serve as control participants. They will undergo the baseline assessment and the post-intervention assessment, but will not do the VR-based training. Following informed consent, baseline assessments will be conducted and demographic and injury-related data will be collected. Some of the tests that will be used in the study will already have been administered as part of the clinical routine. These tests will not be re-administered in the pre-assessment. Following informed consent, the clinical psychologist who has assessed the patient will hand over the test results along with demographic and injury-related data to the responsible researcher. Post-intervention assessments will be conducted after the 5-week training period and before the patient is discharged. All measures from the pre-assessment will be readministered, except WAIS (Wechsler Adult Intelligence Scale)-IV Matrix Reasoning, Rey Auditory Verbal Learning Task, Rey Complex Figure Task. We do not expect an intervention effect on these measures but they are potentially modifiers of treatment effect. A satisfaction questionnaire developed in house will be used and will only be administered post-intervention. In the feasibility study, the focus will be to evaluate different VR games and headsets, the optimal intensity and duration of the VR-based training sessions, and the appropriate level and format of therapist involvement during the intervention. Results on the SIMS and the satisfaction questionnaire will be emphasized, but pre- to post changes on all measures will be calculated.

Interventions

BEHAVIORALVR/AR intervention

Participants will engage in cognitively demanding games such as Beat Saber, Zooma, or XR Brain Stimulation for 30-60 minutes, 3 days a week for 5 weeks using an augmented reality (AR) (RehAtt® XR) or VR headset (i.e., Meta Quest 3 or Oculus Rift S). Beat Saber and Zooma are both commercially available games. In Beat Saber players use two colored sabers to slice incoming music-synchronized blocks in the directions indicated, while also dodging obstacles like walls and bombs. Zooma involves shooting rolling colored balls to create matches before they reach the endpoint ("snapdragon"), using both hands for faster color-matching. XR Brain Stimulation is developed to be used in brain injury rehabilitation and involves 3D games in the form of holograms integrated in the real surroundings.

Sponsors

Danderyd Hospital
Lead SponsorOTHER
Stiftelsen Promobila
CollaboratorUNKNOWN

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Participants will be recruited from both the inpatient and outpatient units at the Department of Rehabilitation Medicine, Danderyd Hospital. Inclusion criteria: 1. Patients with acquired brain injury in need of multiprofessional rehabilitation admitted to the clinic are eligible if they 2. are between 18 and 65 years; 3. present with attention deficits and 4. are deemed suitable for direct attention training by the rehabilitation team.

Exclusion criteria

1. Epilepsy or suspected epilepsy; 2. non-fluent in Swedish 3. severe fatigue or/and cognitive dysfunction that makes participation difficult.

Design outcomes

Primary

MeasureTime frameDescription
WAIS-IV Codingbefore the intervention and within 3 weeks after the interventionmeasures processing speed.
Color-Word Interference Testbefore the intervention and within 3 weeks after the interventionmeasures cognitive flexibility and selective attention.
The Conners Continuous Performance Test (CPT)-IIIbefore the intervention and within 3 weeks after the interventionmeasures sustained attention, reaction time, and impulsivity.
d2 Test of Attentionbefore the intervention and within 3 weeks after the interventionmeasures selective and sustained attention, concentration, and processing speed
WAIS-IV digit spanbefore the intervention and within 3 weeks after the interventionDigit span forwards measures short-term memory, attention and auditory processing ability. Digit span backwards measures working memory and mental processing ability

Secondary

MeasureTime frameDescription
Patient Competency Rating Scale (PCRS)before the intervention and within 3 weeks after the interventionis a 30-item questionnaire in which the respondent on a 5-point Likert scale rate his or her degree of difficulty in a variety of everyday tasks.
Satisfaction questionnairewithin 3 weeks after the interventionA satisfaction questionnaire developed in-house
Situational Motivation Scale (SIMS)before the intervention and within 3 weeks after the interventionconsist of 16 items and measures intrinsic and extrinsic motivation in different situations and activities.
Hospital Anxiety and Depression Scale (HADS)before the intervention and within 3 weeks after the interventiona 14-item questionnaire used to screen for symptoms of anxiety and depression, particularly in medical settings.
Mental Fatigue Scale (MFS)before the intervention and within 3 weeks after the interventiona 15-item self-report questionnaire used to assess mental fatigue, often after brain injury, neurological illness, or concussion. It measures difficulties such as fatigue, lack of initiative, mental
The Rivermead Post-Concussion Symptoms Questionnaire (RPQ)before the intervention and within 3 weeks after the interventiona 16-item self-report tool used to measure the severity of post-concussion symptoms after a traumatic brain injury.
Canadian Occupational Performance Measurement (COPM)before the intervention and within 3 weeks after the interventionis a is a client-centered assessment that identifies daily activities a person wants, needs, or is expected to do but has difficulty performing. It uses a structured interview to help the client rate the importance, performance, and satisfaction of chosen activities. The scores are then used to guide treatment and measure change over time.

Countries

Sweden

Contacts

CONTACTJonas Stenberg, PhD
jonas.stenberg@regionstockholm.se0046702699536
PRINCIPAL_INVESTIGATORJonas Stenberg, PhD

Danderyd Hospital / Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026